We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JBL icon
601
Jabil
JBL
$32.8B
$14.4M 0.03%
210,456
-894,970
-81% -$59.2M
CSTA
602
DELISTED
Constellation Acquisition Corp I
CSTA
$14.3M 0.03%
1,410,829
CVS icon
603
CVS Health
CVS
$137B
$14.3M 0.03%
152,953
+91,905
+151% +$8.87M
GDX icon
604
PUT
VanEck Gold Miners ETF
GDX
$23B
$14.2M 0.03%
497,100
-174,100
-26% -$4.65M
EVRG icon
605
Evergy
EVRG
$20.1B
$14.2M 0.03%
+225,943
New +$13.6M
BAC icon
606
CALL
Bank of America
BAC
$435B
$14.2M 0.03%
428,800
-92,600
-18% -$3.19M
YPF icon
607
YPF
YPF
$20.2B
$14.1M 0.03%
1,539,342
-842,106
-35% -$6.5M
FXI icon
608
PUT
iShares China Large-Cap ETF
FXI
$4.31B
$14.1M 0.03%
499,300
-605,800
-55% -$15.7M
GRBK icon
609
Green Brick Partners
GRBK
$3.13B
$14.1M 0.03%
582,696
+119,564
+26% +$2.76M
IBM icon
610
IBM
IBM
$202B
$14.1M 0.03%
100,160
+53,569
+115% +$7.39M
ACRV icon
611
Acrivon Therapeutics
ACRV
$68.5M
$14.1M 0.03%
+1,223,252
New +$15.5M
GDX icon
612
CALL
VanEck Gold Miners ETF
GDX
$23B
$14.1M 0.03%
491,100
-532,600
-52% -$14.2M
BSLK
613
DELISTED
Bolt Projects Holdings
BSLK
$14.1M 0.03%
70,173
CPAR
614
DELISTED
Catalyst Partners Acquisition Corp. Class A Ordinary Share
CPAR
$14M 0.03%
1,391,488
SCI icon
615
Service Corp International
SCI
$11.4B
$13.9M 0.03%
201,501
+119,980
+147% +$7.99M
DRAY
616
DELISTED
Macondray Capital Acquisition Corp. I Class A Ordinary Shares
DRAY
$13.9M 0.03%
1,365,939
FOXA icon
617
Fox Class A
FOXA
$23.2B
$13.9M 0.03%
457,108
+446,908
+4,381% +$13.6M
HYG icon
618
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$13.9M 0.03%
188,500
-973,200
-84% -$71.7M
STRE
619
DELISTED
Supernova Partners Acquisition Company III, Ltd.
STRE
$13.9M 0.03%
1,374,975
AGAC.WS
620
CALL
DELISTED
African Gold Acquisition Corp Warrants
AGAC.WS
$13.8M 0.03%
1,377,874
BXMT icon
621
Blackstone Mortgage Trust
BXMT
$2.82B
$13.8M 0.03%
+653,665
New +$15.5M
USFD icon
622
PUT
US Foods
USFD
$21.4B
$13.7M 0.03%
+402,900
New +$12.9M
NFNT
623
DELISTED
Infinite Acquisition Corp.
NFNT
$13.7M 0.03%
1,336,691
SLND icon
624
Southland Holdings
SLND
$33.6M
$13.6M 0.03%
1,348,221
PSPC
625
DELISTED
Post Holdings Partnering Corporation
PSPC
$13.6M 0.03%
1,371,746

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.